4//SEC Filing
Byrnes Michael 4
Accession 0001209191-22-034881
CIK 0001828522other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:30 PM ET
Size
5.2 KB
Accession
0001209191-22-034881
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-06-07$1.33/sh+25,000$33,263→ 29,233 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.275 to $1.360. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001619893
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 5:30 PM ET
- Size
- 5.2 KB